Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulcrum Therapeutics (FULC) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to -$44000.0.

  • Fulcrum Therapeutics' Other Working Capital Changes rose 9342.3% to -$44000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.7 million, marking a year-over-year decrease of 52889.73%. This contributed to the annual value of -$2.0 million for FY2024, which is 28666.04% down from last year.
  • According to the latest figures from Q3 2025, Fulcrum Therapeutics' Other Working Capital Changes is -$44000.0, which was up 9342.3% from $288000.0 recorded in Q2 2025.
  • Fulcrum Therapeutics' Other Working Capital Changes' 5-year high stood at $1.7 million during Q4 2023, with a 5-year trough of -$4.3 million in Q1 2021.
  • In the last 5 years, Fulcrum Therapeutics' Other Working Capital Changes had a median value of -$669000.0 in 2024 and averaged -$1.0 million.
  • As far as peak fluctuations go, Fulcrum Therapeutics' Other Working Capital Changes plummeted by 63540.59% in 2021, and later skyrocketed by 46747.25% in 2023.
  • Quarter analysis of 5 years shows Fulcrum Therapeutics' Other Working Capital Changes stood at -$1.4 million in 2021, then soared by 67.96% to -$455000.0 in 2022, then surged by 467.47% to $1.7 million in 2023, then plummeted by 103.95% to -$66000.0 in 2024, then surged by 33.33% to -$44000.0 in 2025.
  • Its last three reported values are -$44000.0 in Q3 2025, $288000.0 for Q2 2025, and -$1.8 million during Q1 2025.